Updated: Mar 3
March 1, 2021
President Joseph R Biden, Jr.
The White House
1600 Pennsylvania Ave. NW
Washington, DC 20500
Mr. Jeffrey Zients
Coordinator and Counselor to the President
COVID-19 Pandemic Response
Rochelle P. Walensky, MD, MPH
Director, Centers for Disease Control and Prevention
Anthony S. Fauci, MD
Director, National Institute of Allergy and Infectious Diseases
National Institutes of Health
Re: The United States has the Manufacturing Capacity to Provide High-Filtration Masks to Every American
Dear President Biden and Team:
As 50 independent American Mask Manufacturers, we’re writing to call attention to a Feb 15 letter titled “Re: Immediate Action is Needed to Address SARS-CoV-2 Inhalation Exposure” sent by America’s Physicians and Scientists to your administration urging immediate action to improve measures that limit inhalation exposure to SARS-CoV-2. We could not agree more.
We, the undersigned, represent a robust supply chain for masks and Barrier Face Coverings. At the outset of COVID-19, we have worked hand-in-hand with federal officials to supply quality masks when called upon. We produce products that are superior to those made in other countries like China. We recognize your Administration’s COVID-19 plan calls for widespread use of masks to protect workers. And, we agree with the Feb 15 letter that stronger protective measures are needed immediately to limit exposure and transmission of the SARS-CoV-2 virus to control and end the pandemic. As OSHA contemplates implementing an Emergency Temporary Standard on Protecting Worker Health and Safety by March 15, we strongly recommend using the new ASTM Barrier Face Covering Standard at an 80% filtration level. The U.S. has ample supply of masks and filter material to protect the entire workforce and public.
In addition, hospitals are rationing PPE, leading to health care workers quitting because they cannot secure sufficient supplies of quality supplies necessary to achieve the minimum protection needed. Many workers, especially low-income workers, do not have these basic levels of protection here in the United States. Our allies Germany, Austria and France have all recently taken actions to stop PPE rationing by mandating the quality of respiratory protection. The United States should do the same.
We want to assure you that America’s mask manufacturers have ample capacity to meet the entire needs of our nation during emergencies such as this pandemic. As good partners of the administration, our capacity can also serve as the foundation for future emergency response.
More specifically, today we are capable of delivering:
690 million high-filtration masks sitting in American warehouses ready to ship, containing:
233.4 million N95 respirators (or equivalents)
50,000 reusable elastomeric respirators
Current monthly production capacity of 902.3 million made-in-America masks, consisting of:
603.5 million surgical masks
298 million N95 respirators (or equivalents)
671,000 reusable elastomeric respirators
In partnership with the federal government, we are capable of expanding operations or other actions necessary to meet your Administration's needs now and in the future. With less than $75 million in Title III funding we can collectively grow our monthly production to over 3 billion — enough masks to protect all Americans.
President Biden, we know you are considering using the Defense Production Act to ramp up production, specifically from massive U.S. manufacturers, who primarily source their PPE from China. However, we the members of the American Mask Manufacturers Association can say unequivocally and with detailed accounting, that America’s independently-run manufacturers are able to produce enough high-filtration masks today to protect every American in need. The only missing component is a formal collaboration with the Federal Government.
In support of our shared interests for the safety and health of all Americans, we ask that you strongly consider the following actions:
Advise the CDC to issue clear science-backed guidance so that American’s can easily identify and adopt the new standards.
Take measures to end the practice of rationing critical PPE supplies and provide them with funding needed to protect HCWs.
Urge HSS or the Department of Defense to issue Title III funding to mitigate risk for our manufactures to increase production.
Provide guidance on strategic distribution of these American-made masks.
Explore formal partnerships with American domestic manufacturers as part of continuing efforts to respond to COVID-19 and future emergencies.
Thank you Mr. President and your Administration for your strong leadership and efforts to protect the American public as well as workers from this deadly virus. Through partnership and collaboration we can end this pandemic.
Lloyd Armbrust, Founder, Armbrust Inc. Landon Morales, President, Armbrust Inc. Chris Dement, Co-Founder, Premium-PPE Brent Dillie, Commercial Director, Premium-PPE Luis Arguello Jr., Vice President, DemeTech Corporation
Howard Sherman, CEO, Premier Guard USA Glenn Ferreri, President, Premier Guard USA Massimo Scagliarini, CEO, GVS Dan Izhaky, President, United Safety Technology, Inc Brian Wolin, CEO, Protective Health Gear Amir Tafreshi, Founder & CEO, Lutema USA Eddie Phanichkul, Founder & CMO, Lutema USA John Chang, Founder & CTO, PZero Innovations Inc. Charles Park, PZero Innovations Inc. Paul Hickey, President & Co-Founder, PureVita Bob Hyslop, Director of Sales, Ecoguard Sabrina Paseman, CEO, Fix The Mask Katherine Paseman, COO, Fix The Mask Todd Raines, President, NFI Masks LLC Jason Popp, CEO, Moss Inc. Matthew Lane, CEO, Lane Care LLC Clayton Geye, CEO , Indiana Face Mask Andrew Sisnett, President, Dorma Suzie Wang, President, WYZ Medical Supplies Barry Hunt, President, Prescient John A. Schwind, CEO, Global Safety First, LLC Marc Etchells, CEO, ETC BIOMED Dan Castle, CEO, CastleGrade Chris Evans, CEO, Aries USA Matt Hubbard, President, Texas Mask Incorporated Jeremy A. Briggs, Esq., President, Luosh USA Matt Brandman, CEO, American Surgical Mask Kahoru Watanabe, Co-Founder, American Surgical Mask Tim Ziegenfus, CEO, ATI Corporation of North America Richard Gehricke, COO, ATI Corporation of North America Max Bock-Aronson, CEO, Breathe99 PBC Alison Lee, Director of Operations, Breathe99 PBC Joseph Rosenberg, CEO, Canopy Ryan Gehricke, COO, Carolina Facemask and PPE Pat Masterson, MaskForce Rob Moran, President, Enny Dakota Hendrickson, Founder, Filti George Tsatsos, VP of Sales, Filti Michael Bolden, VP Sales, Dentec Mike Rushton, Sales Director, Design Reality RTL Kevin McCarthy, Global Sales Manager, EnvoMask Robert Skaff, Business Manager, EnvoMask Rodney McAbery, VP Sales & Operations, Guardsman Global Dan Grayson, Vice President Sales & Operations, TMS, Inc. Amanda Engel , Director of Media, The Fischer Group Lee Mornan, VP of Sales & Marketing, Altor Safety Brian Goldmeier, Partner, Made In America PPE Chet Desai, Partner, Made In America PPE David Pettey, Co-Owner, Response Medical, LLC Connor Knapp, Founder, NYPPE LLC Thomas Allen Jr., COO, NYPPE LLC John Bielamowicz, Co-founder, United States Mask Co. David Baillargeon, Co-founder, United States Mask Co. Jason Greene, Owner, Medicair Inc. Avi Polischuk, Owner, Medicair Inc. Kan Chou, President of CW Horizon LLC Adam Harmon, President, ALG Health Michael Heslop, Co-Founder, Never Again Industries Andrew Hetzel Jr, CEO, FyterTech Nonwovens LLC Sara A. Greenstein, President & CEO, Lydall, Inc.
Marcella Nunez-Smith, MD, MHS, Chair, COVID-19 Health Equity Task Force
James S. Frederick, Principal Deputy Assistant Secretary, Occupational Safety and Health Administration
John Howard, MD, MPH, JD, LLM, MBA, Director, National Institute for Occupational Safety and Health
Anne Schuchat, MD Principal Deputy Director, Centers for Disease Control and Prevention
Timothy Manning, Supply Coordinator, White House COVID-19 Response
Click here to read letter in PDF Format: